Advertisement
The prevalence of asthma is about 10 percent higher for children with versus those without a disability

Prevalence of Asthma Up for Children With Disability

0
Odds of asthma significantly higher for children with a disability or delay versus typically growing children
A proactive monitoring program for COVID-19 can track illness

Proactive Monitoring Program Beneficial for COVID-19 Home Care

0
Total of 6,853 patients monitored as of May 21, 2020; average of nine patients/day sent to ED
After reopening

Record-High Spikes in COVID-19 Cases Seen in Arizona, Florida, Texas

0
Why numbers are rising has become a point of argument between politicians and scientists
Health insurance companies are expected to cover vaccines for the new coronavirus without charging copays

U.S. Insurers Should Not Charge Copays for COVID-19 Vaccine

0
Government has been in discussions with insurers about covering COVID-19 vaccination at no cost to patients
Most adults in New York City

Strong Support Found for Protective Practices Related to COVID-19

0
Most adults in N.Y.C., L.A., and across the U.S. support stay-at-home orders, closure of nonessential business
The rate of COVID-19 cases is increased on American Indian reservations with larger proportions of homes lacking complete indoor plumbing

Correlates of COVID-19 ID’d on American Indian Reservations

0
Rate of cases higher on American Indian reservations with larger proportion of homes lacking plumbing
Greater health system use and higher costs are seen with nine months of isoniazid compared with four months of rifampin in both adults and children treated for latent tuberculosis infection

Four Months of Rifampin Costs Less Than Nine Months Isoniazid

0
Health system use and costs higher for nine months of isoniazid in adults and children in all settings
Mandated face coverings represent the most effective means to prevent interhuman transmission of COVID-19

Face Masks Most Effective Means to Avert COVID-19 Transmission

0
Airborne transmission is dominant route for spread; masks are determinant for shaping pandemic trend
In the treatment of COVID-19 patients

Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients

0
FDA says chloroquine or hydroxychloroquine could reduce the antiviral effectiveness of remdesivir
The cumulative incidence of COVID-19 is 403.6 cases per 100

CDC: Cumulative Incidence of COVID-19 403.6 Per 100,000 in U.S.

0
Hospitalization and mortality six times, 12 times higher for patients reporting an underlying condition